The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients (pts) with advanced gastro-intestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib (IM) as first-line treatment.
 
Alice Boileve
No Relationships to Disclose
 
Armelle Dufresne
No Relationships to Disclose
 
Ali N. Chamseddine
No Relationships to Disclose
 
Sarah Naomie Dumont
No Relationships to Disclose
 
Medhi Brahmi
No Relationships to Disclose
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - Merck Sharp & Dohme (Inst); Pierre Fabre (Inst)
 
Etienne Rouleau
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Marie Karanian
No Relationships to Disclose
 
Veronique Haddad
No Relationships to Disclose
 
Matthieu Faron
Honoraria - Novartis (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Charles Honoré
No Relationships to Disclose
 
Pierre Meeus
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer; Lilly; PharmaMar
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Pharmamar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Olivier Mir
Stock and Other Ownership Interests - Amplitude Surgical; Ipsen; Transgene
Honoraria - Roche
Consulting or Advisory Role - Janssen; Lilly; Lundbeck; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche